(Q58371210)

Gad Cotter

9

0 references

Gary Felker

G. Michael Felker

6

0 references

Christopher M O'Connor

3

Christopher M. O'Connor

0 references

Beth D. Weatherley

7

Beth Weatherley

0 references

Kirkwood F Adams

2

Kirkwood F. Adams

0 references

Olga Milo-Cotter

1

Olga Milo-Cotter

0 references

Nir Uriel

4

Nir Uriel

0 references

Zvi Vered

8

European Journal of Heart Failure

Zvi Vered

0 references

publication date

February 2007

0 references

published in

0 references

volume

9

0 references

issue

2

0 references

page(s)

178-183

0 references

cites work

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

The problem of decompensated heart failure: nomenclature, classification, and risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Acute heart failure: a novel approach to its pathogenesis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Diastolic heart failure. Paroxysmal or chronic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Age- and gender-related ventricular-vascular stiffening: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.06.004